Relugolix: Early Promise for a Novel Oral Androgen Deprivation Therapy with Radiation Therapy for Prostate Cancer

Eur Urol. 2020 Aug;78(2):193-194. doi: 10.1016/j.eururo.2020.03.053. Epub 2020 Apr 25.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists*
  • Androgens
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Phenylurea Compounds
  • Prostatic Neoplasms*
  • Pyrimidinones
  • Receptors, LHRH

Substances

  • Androgen Antagonists
  • Androgens
  • Phenylurea Compounds
  • Pyrimidinones
  • Receptors, LHRH
  • relugolix